Primary cardiac angiosarcoma

Sarcoma

Volumn 2006, Issue , 2006, Pages

  Kodali, Dhatri ^a   Seetharaman, Kala ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Fallon Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; MESNA;

ABSENCE OF SIDE EFFECTS; AGED; ANGIOSARCOMA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CASE REPORT; FEMALE; HEART TUMOR; HUMAN; LUNG METASTASIS; PRIORITY JOURNAL; STERNOTOMY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; TUMOR DIAGNOSIS;

EID: 34547926536     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/SRCM/2006/39130     Document Type: Article

References (19)

1. P Baay S V Karwande J P Kushner S Olsen D G Renlund Successful treatment of a cardiac angiosarcoma with combined modality therapy. Journal of Heart and Lung Transplantation 13 5 1994 923 925
2. D Bafaloukos dimmp@otenet.gr C Papadimitriou H Linardou Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group. British Journal of Cancer 91 9 2004 1639 1644
3. T Chidiac G T Budd buddg@.ccf.org R Pelley Phase II trial of liposomal doxorubicin (Doxil®) in advanced soft tissue sarcomas. Investigational New Drugs 18 3 2000 253 259
4. M G Crespo L A Pulpon G Pradas Heart transplantation for cardiac angiosarcoma: should its indication be questioned? Journal of Heart and Lung Transplantation 12 3 1993 527 530
5. F Fata E O'Reilly D Ilson Paclitaxel in the treatment of patients with anglosarcoma of the scalp or face. Cancer 86 10 1999 2034 2037
6. A A Garcia R A Kempf M Rogers F M Muggia A phase II study of Doxil (liposomal doxorubicin): lack of activity in poor prognosis soft tissue sarcomas. Annals of Oncology 9 10 1998 1131 1133
7. M A Herrmann R A Shankerman W D Edwards C Shub H V Schaff Primary cardiac angiosarcoma: a clinicopathologic study of six cases. Journal of Thoracic and Cardiovascular Surgery 103 4 1992 655 664
8. D T Janigan A Husain N A Robinson Cardiac angiosarcomas. A review and a case report. Cancer 57 4 1986 852 859
9. I Judson J A Radford M Harris Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. European Journal of Cancer 37 7 2001 870 877
10. S Kakizaki kakizaki@sb.gunma-u.ac.jp H Takagi Y Hosaka Cardiac angiosarcoma responding to multidisciplinary treatment. International Journal of Cardiology 62 3 1997 273 275
11. A Llombart-Cussac X Pivot G Contesso Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience. British Journal of Cancer 78 12 1998 1624 1628
12. R E Michler D J Goldstein Treatment of cardiac tumors by orthotopic cardiac transplantation. Seminars in Oncology 24 5 1997 534 539
13. B Movsas J Teruya-Feldstein J Smith E Glatstein A H Epstein Primary cardiac sarcoma: a novel treatment approach. Chest 114 2 1998 648 652 Selected Reports
14. J B Jr Putnam M S Sweeney R Colon L A Lanza O H Frazier D A Cooley Primary cardiac sarcomas. Annals of Thoracic Surgery 51 6 1991 906 910
15. K M Skubitz Phase II trial of pegylated-liposomal doxorubicin ( Doxil TM) in sarcoma. Cancer Investigation 21 2 2003 167 176
16. K M Skubitz skubi001@umn.edu P A Haddad Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer 104 2 2005 361 366
17. S Stewart simon@dukeau.demon.co.uk H Jablonowski F D Goebel Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group. Journal of Clinical Oncology 16 2 1998 683 691
18. S M Talbot R N Taub M L Keohan N Edwards M E Galantowicz L L Schulman LLS2@columbia.edu Combined heart and lung transplantation for unresectable primary cardiac sarcoma. Journal of Thoracic and Cardiovascular Surgery 124 6 2002 1145 1148
19. S Toma toma@ermes.cba.unige.it A Tucci G Villani G Carteni N Spadini R Palumbo Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG). Anticancer Research 20 1 B 2000 485 491